Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#131 / 166 Total
JAN - JanOne Inc - Stock Price Chart
TickerJAN [NASD]
CompanyJanOne Inc
Market Cap41.06MEPS (ttm)-4.67
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y23.21%
P/S-EPS next 5Y-
P/B-EPS Q/Q-9.46%
Dividend-Sales Q/Q-100.00%
Insider Own11.05%Inst Own3.61%
Insider Trans0.00%Inst Trans-7.88%
Short Float3.28%Earnings-
Analyst Recom-Target Price-
Avg Volume310.77K52W Range0.22 - 5.08
JanOne, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.
WFRD - Weatherford International plc - Stock Price Chart
CompanyWeatherford International plc
IndustryOil & Gas Equipment & Services
Market Cap9.04BEPS (ttm)6.18
P/E20.24EPS this Y25.67%
Forward P/E14.55EPS next Y20.83%
PEG1.18EPS past 5Y-
P/S1.70EPS next 5Y17.20%
P/B9.74EPS Q/Q54.16%
Dividend-Sales Q/Q14.50%
Insider Own1.96%Inst Own98.28%
Insider Trans-12.25%Inst Trans1.72%
Short Float3.92%EarningsApr 23/a
Analyst Recom1.50Target Price145.74
Avg Volume843.00K52W Range55.81 - 127.45
Weatherford International plc engages in providing equipment and services to the oil and natural gas exploration and production industry. It operates through the following segments: Drilling and Evaluation (DRE), Well Construction and Completions (WCC) and Production and Intervention (PRI). The DRE segment offers managed pressure drilling, drilling services, wire line, and drilling fluids. The WCC segment includes tubular running services, cementation products, completions, liner hangers, and well services. The PRI segment covers the intervention services and drilling tools, artificial lift, production automation and software, sub-sea intervention, and pressure pumping services. The company was founded in 1941 and is headquartered in Houston, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Saligram GirishPresident and CEOFeb 21 '24Sale103.5760,0006,214,136146,895Feb 23 05:05 PM
Sandhu DepinderEVP, Global Product LinesFeb 15 '24Sale100.964,717476,2092,536Feb 16 04:47 PM
Mutschler Jacqueline CDirectorFeb 15 '24Sale99.453,000298,35028,801Feb 16 04:44 PM
Reed David JohnEVP, Chief Commercial OfficerFeb 15 '24Sale97.502,700263,2506,805Feb 16 04:46 PM
Duster BenjaminDirectorFeb 12 '24Sale96.9812,0001,163,78512,801Feb 12 05:40 PM
MTEM - Molecular Templates Inc - Stock Price Chart
CompanyMolecular Templates Inc
Market Cap8.81MEPS (ttm)-1.56
P/E-EPS this Y-80.56%
Forward P/E-EPS next Y-20.92%
PEG-EPS past 5Y34.83%
P/S0.15EPS next 5Y3.20%
P/B2.09EPS Q/Q87.48%
Dividend-Sales Q/Q168.71%
Insider Own45.15%Inst Own50.57%
Insider Trans11.50%Inst Trans-24.09%
Short Float1.14%EarningsMar 29/b
Analyst Recom1.00Target Price18.00
Avg Volume62.93K52W Range1.40 - 9.45
Apr-11-24 01:52PM MTEM Stock Earnings: Molecular Templates Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
Apr-09-24 08:11AM Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer Patients Observed Through Novel Immuno-oncology Mechanism (GlobeNewswire) -6.57%
Mar-29-24 08:21AM Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update (GlobeNewswire)
Mar-28-24 08:11AM Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement (GlobeNewswire) -5.08%
Mar-04-24 08:11AM Molecular Templates, Inc. Provides Interim Update (GlobeNewswire)
Feb-08-24 05:55PM Molecular Templates to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference (GlobeNewswire)
Nov-13-23 04:11PM Molecular Templates, Inc. Reports Third Quarter 2023 Financial Results and Business Update (GlobeNewswire)
Nov-02-23 04:11PM Molecular Templates Announces First Patient Dosed in Phase 1 Trial Evaluating MT-8421, a Novel Engineered Toxin Body Targeting CTLA-4, in Advanced Solid Tumors (GlobeNewswire)
Nov-01-23 04:12PM Molecular Templates to Participate in Upcoming Investor Conferences (GlobeNewswire) -9.09%
Sep-28-23 04:11PM Molecular Templates Announces the Appointment of Dr. Maurizio Voi to the Role of Chief Medical Officer (GlobeNewswire)
Molecular Templates, Inc. engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. It utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. The company was founded by Eric E. Poma, Jean Gariepy, and Leigh Revers in 2001 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BIOTECH TARGET N V10% OwnerApr 02 '24Buy2.35250,000587,5001,279,820Apr 04 08:13 PM
BIOTECH TARGET N V10% OwnerJul 17 '23Buy0.474,255,3192,000,00015,447,322Jul 19 03:14 PM
XAIR - Beyond Air Inc - Stock Price Chart
CompanyBeyond Air Inc
IndustryMedical Devices
Market Cap58.75MEPS (ttm)-2.11
P/E-EPS this Y-5.05%
Forward P/E-EPS next Y6.76%
PEG-EPS past 5Y9.16%
P/S85.15EPS next 5Y-
P/B2.18EPS Q/Q-17.28%
Dividend-Sales Q/Q-
Insider Own22.91%Inst Own20.43%
Insider Trans13.61%Inst Trans10.31%
Short Float9.88%EarningsFeb 12/a
Analyst Recom1.00Target Price13.00
Avg Volume306.75K52W Range1.13 - 6.36
Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in developing a platform for nitric oxide generators and delivery systems. It operates through the Beyond Air and Beyond Cancer segments. The company was founded on April 28, 2015 and is headquartered in Garden City, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Avniel AmirChief Business OfficerDec 28 '23Sale2.0513,73328,2170Dec 29 04:23 PM
Avniel AmirChief Business OfficerDec 28 '23Sale2.0611,26723,234685,760Dec 29 04:23 PM
Myers Jeff LynnChief Medical OfficerDec 27 '23Sale2.213,4237,57946,577Dec 29 04:15 PM
Carey RobertDirectorDec 18 '23Buy1.641,200,0001,962,0002,374,454Dec 19 05:13 PM
Lisi Steven A.CEO and Chairman of the BoardDec 18 '23Buy1.6377,775126,7971,536,471Dec 19 05:15 PM
BSX - Boston Scientific Corp. - Stock Price Chart
TickerBSX [NYSE, S&P 500]
CompanyBoston Scientific Corp.
IndustryMedical Devices
Market Cap107.17BEPS (ttm)1.07
P/E68.12EPS this Y12.40%
Forward P/E27.91EPS next Y13.37%
PEG5.55EPS past 5Y-2.05%
P/S7.53EPS next 5Y12.28%
P/B5.54EPS Q/Q290.50%
Dividend-Sales Q/Q14.90%
Insider Own0.45%Inst Own93.81%
Insider Trans-5.27%Inst Trans0.92%
Short Float0.85%EarningsApr 24/b
Analyst Recom1.41Target Price79.16
Avg Volume6.42M52W Range48.35 - 69.21
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sorenson John BradleyEVP, Global OperationsApr 01 '24Option Exercise16.3116,351266,68566,989Apr 02 06:57 PM
Carruthers WendyEVP, Human ResourcesApr 01 '24Option Exercise19.314,26382,30658,051Apr 02 06:57 PM
Sorenson John BradleyEVP, Global OperationsApr 01 '24Sale69.3016,3511,133,06950,638Apr 02 06:57 PM
Carruthers WendyEVP, Human ResourcesApr 01 '24Sale68.426,983477,77751,068Apr 02 06:57 PM
Mirviss Jeffrey B.EVP&Pres, Periph InterventMar 18 '24Sale66.4514,506963,93058,098Mar 19 04:41 PM
TXN - Texas Instruments Inc. - Stock Price Chart
TickerTXN [NASD, NDX, S&P 500]
CompanyTexas Instruments Inc.
Market Cap159.09BEPS (ttm)6.42
P/E27.24EPS this Y-28.25%
Forward P/E27.62EPS next Y24.78%
PEG2.72EPS past 5Y4.81%
P/S9.47EPS next 5Y10.00%
P/B9.37EPS Q/Q-35.30%
Dividend2.97%Sales Q/Q-16.40%
Insider Own0.23%Inst Own87.68%
Insider Trans-0.67%Inst Trans-1.36%
Short Float2.06%EarningsApr 23/a
Analyst Recom2.71Target Price176.76
Avg Volume5.41M52W Range139.48 - 188.12
Apr-24-24Reiterated TD Cowen Hold $160 → $175
Texas Instruments Incorporated engages in the design and manufacture of semiconductors. It operates through the following segments: Analog, Embedded Processing, and Other. Analog semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded processors. The Embedded Processing segment involves handling specific tasks and can be optimized for various combinations of performance, power, and cost, depending on the application. The company was founded in 1930 and is headquartered in Dallas, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BLINN MARK ADirectorJan 31 '24Option Exercise130.52978127,64913,437Feb 02 04:46 PM
BLINN MARK ADirectorJan 31 '24Sale159.851,744278,77611,693Feb 02 04:46 PM
KIRK RONALDDirectorNov 13 '23Option Exercise44.0912,299542,26325,936Nov 15 04:40 PM
KIRK RONALDDirectorNov 13 '23Sale145.5112,2991,789,60213,637Nov 15 04:40 PM
COX CARRIE SMITHDirectorJul 31 '23Option Exercise62.8816,0551,009,48351,856Aug 03 01:06 PM
BTOG - Bit Origin Ltd - Stock Price Chart
CompanyBit Origin Ltd
IndustryCapital Markets
Market Cap15.54MEPS (ttm)-9.68
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S2.48EPS next 5Y-
P/B0.93EPS Q/Q46.83%
Dividend-Sales Q/Q-71.60%
Insider Own11.31%Inst Own0.65%
Insider Trans0.00%Inst Trans-
Short Float5.77%Earnings-
Analyst Recom-Target Price-
Avg Volume527.39K52W Range1.25 - 9.71
Bit Origin Ltd. operates as an emerging growth company which engages in crypto mining business. The firm also actively deploys blockchain technologies, alongside diversified expansion strategies. It has operations in the United States, Canada, and China. The company was founded on January 23, 2018 and is headquartered in New York, NY.
SILO - SILO Pharma Inc - Stock Price Chart
CompanySILO Pharma Inc
Market Cap5.34MEPS (ttm)-1.21
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-4.01%
P/S76.27EPS next 5Y-
P/B0.88EPS Q/Q26.71%
Dividend-Sales Q/Q0.00%
Insider Own10.33%Inst Own5.65%
Insider Trans6.62%Inst Trans-
Short Float2.41%Earnings-
Analyst Recom1.00Target Price10.00
Avg Volume217.04K52W Range1.22 - 3.05
Silo Pharma, Inc. is a developmental stage biopharmaceutical company, which engages in the merging of traditional therapeutics with psychedelic research. It seeks to acquire and develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs. The company was founded by Eric Weisblum on July 13, 2010 and is headquartered in Sarasota, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Weisblum EricCEO and PresidentApr 05 '24Buy2.03400812175,432Apr 08 04:00 PM
Weisblum EricCEO and PresidentApr 04 '24Buy1.966001,176175,032Apr 08 04:00 PM
Weisblum EricCEO and PresidentApr 01 '24Buy1.911,1002,101174,432Apr 01 06:15 PM
Weisblum EricCEO and PresidentMar 28 '24Buy1.943,4086,612173,332Apr 01 06:15 PM
Weisblum EricCEO and PresidentDec 20 '23Buy1.61200322169,924Dec 21 04:13 PM
BACK - IMAC Holdings Inc - Stock Price Chart
CompanyIMAC Holdings Inc
IndustryMedical Care Facilities
Market Cap4.01MEPS (ttm)-13.61
P/E-EPS this Y57.26%
Forward P/E-EPS next Y0.00%
PEG-EPS past 5Y10.09%
P/S0.47EPS next 5Y-
P/B-EPS Q/Q62.03%
Dividend-Sales Q/Q-58.64%
Insider Own18.39%Inst Own5.76%
Insider Trans0.00%Inst Trans-
Short Float93.63%Earnings-
Analyst Recom1.00Target Price8.00
Avg Volume830.53K52W Range1.22 - 6.28
IMAC Holdings, Inc. provides medical services through integrated medicine and chiropractic regeneration centers. Its services include medical treatments, regenerative medicine, physical medicine, physical therapy, spinal decompression and chiropractic manipulation. The company was founded by Matthew C. Wallis, Jason William Brame and Jeffrey S. Ervin in August 2000 and is headquartered in Franklin, TN.
SOHO - Sotherly Hotels Inc - Stock Price Chart
CompanySotherly Hotels Inc
IndustryREIT - Hotel & Motel
Market Cap26.60MEPS (ttm)-0.21
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y12.52%
P/S0.15EPS next 5Y0.00%
P/B0.54EPS Q/Q-185.29%
Dividend-Sales Q/Q1.95%
Insider Own22.19%Inst Own24.56%
Insider Trans0.00%Inst Trans28.36%
Short Float0.44%EarningsMay 09/b
Analyst Recom3.00Target Price2.00
Avg Volume41.83K52W Range1.13 - 2.50
Sotherly Hotels, Inc. is a real estate investment trust. It engages in the business of acquisition, renovation, upbranding, and repositioning of upscale to upper-upscale full-service hotels. The company was founded in August 2004 and is headquartered in Williamsburg, VA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sims AndrewChairmanSep 20 '23Sale1.801,1332,040326,570Sep 20 04:31 PM
Sims AndrewChairmanSep 18 '23Sale1.80200360327,703Sep 20 04:31 PM